Lower Plasma β-Amyloid 1-42 Levels in Amnestic Mild Cognitive Impairment Compared to Healthy Individuals
BACKGROUND: Amnestic mild cognitive impairment (aMCI) is strongly associated with an increased risk of progression to Alzheimer’s disease (AD). In AD, cerebrospinal fluid (CSF) β-Amyloid 1-42 levels are known to decrease, a pattern which is also observed in aMCI. While in AD, apolipoprotein E (ApoE)...
Saved in:
Main Authors: | Cynthia Cynthia, Jusak Nugraha, Muhammad Hamdan, Hari Basuki Notobroto, Silvia Francina Lumempouw, Rahajuningsih Dharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Secretariat of The Indonesian Biomedical Journal
2024-12-01
|
Series: | Indonesian Biomedical Journal |
Online Access: | https://inabj.org/index.php/ibj/article/view/3404 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Abstract Word Definition in Patients with Amnestic Mild Cognitive Impairment
by: Soo Ryon Kim, et al.
Published: (2015-01-01) -
Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
by: Rosolino Camarda, et al.
Published: (2007-01-01) -
Online applications as a protective factor for amnestic mild cognitive impairment
by: Yordanis Garbey Pierre, et al.
Published: (2024-05-01) -
Examining Specific Theory-of-Mind Aspects in Amnestic and Non-Amnestic Mild Cognitive Impairment: Their Relationships with Sleep Duration and Cognitive Planning
by: Areti Batzikosta, et al.
Published: (2025-01-01) -
Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer’s disease
by: Yali Xu, et al.
Published: (2025-01-01)